Research-for-Cure Academy

Tanya Nielson

Nationality: South African
Institution: The Aurum Institute
Country of work: South Africa

What is your motivation for engaging in HIV cure and remission research?

With great improvements in antiretroviral treatment, HIV/AIDS has become a manageable chronic condition. Advances in HIV prevention provides patients with a variety of choices to protect themselves against HIV, yet this is not the end of the fight against HIV. The successful eradication of HIV will require combined efforts of numerous strategies as a single strategy will not be enough. To date I have been involved in HIV vaccine, - prevention & treatment trials, but have no HIV cure research experience. This is an opportunity to improve my knowledge and understanding of research related to HIV cure and remission.

What is your current area of research?

I am Managing Director for the Clinical Research Division at The Aurum Institute – one of the largest non-governmental organisations in South Africa. I have more than 13 years of clinical trial experience and have been involved in managing the implementation of more than 43 randomised controlled clinical trials (20 DAIDS funded) across three clinical trial sites. Current area of research includes TB vaccines, TB prevention, TB treatment, HIV vaccines, HIV prevention and HIV treatment trials.